The US Food and Drug Administration (FDA) has issued a warning that women using birth control similar to Beyaz birth control could be at increased risk of drospirenone side effects. According to the FDA and researchers, drugs such as Beyaz birth control, which contain drospirenone are associated with an increased risk of blood clots. The FDA is now investigating potential Beyaz side effects and other drospirenone reactions. Although lawsuits have been filed against other birth control makers, so far no Beyaz lawsuits have been filed.
FREE CASE EVALUATION
Send your Beyaz claim to a Lawyer who will review your claim at NO COST
Beyaz Side Effects
On September 26, 2011, the FDA issued a warning that the use of birth control medications that contain drospirenone could potentially be linked to an increased risk of blood clots. The announcement came after the FDA completed a review of two studies from 2011 that evaluated the risk of blood clots in women who use medications that contain drospirenone. Furthermore, the FDA has funded a study that evaluates the risk of blood clots in women who use hormonal birth control products. Preliminary results of that study suggest that women who take a birth control pill containing drospirenone has approximately 1.5 times the risk of blood clots of women who use other hormonal contraceptives.
On May 31, 2011, the FDA issued an alert that the agency was assessing information about the risks associated with the use of drospirenone in birth control pills. According to the announcement, drospirenone is a type of female hormone called progestin.
"All birth control pills pose a risk of blood clots," the FDA announcement stated. "Several epidemiological studies have reported that the risk of blood clots for women who use birth control pills containing drospirenone is higher than that for women who use birth control pills containing the progestin levonorgestrel. Other studies have not reported an increase in risk."
On December 8, 2011, an FDA advisory panel ruled that birth control drugs containing drosperinone should include a warning about the risk of blood clots. The panel voted 21 to 5 that current warnings concerning the risk of blood clots were not strong enough and recommended that the FDA should strengthen those warnings. The panel voted 15 to 11 to keep drospirenone birth control medications on the market.
Blood clots can be serious, especially if they form in a deep vein (a condition called deep vein thrombosis, or DVT). If blood clots break loose from the vein and move to the lung, they can cause a pulmonary embolism, which can be fatal. According to the FDA, two recently published studies found an increased risk for blood clots in women taking drospirenone-containing pills compared with women taking levonorgestrel-containing pills.
Beyaz Blood Clots
A study published in the British Medical Journal (04/21/11) found that women who are currently using contraceptives that contain drospirenone had approximately three times the risk of developing a non-fatal idiopathic venous thromboembolism as women who used contraceptives that contain levonorgestrel.
"This study adds to the emerging evidence that use of the oral contraceptive containing drospirenone is associated with a higher risk of venous thromboemolism than are preparations containing levonorgestrel," researchers wrote. "Perhaps now is the time for a systematic review on this topic." They went on to note that there is no clear evidence that drospirenone pills have greater benefits than contraceptives that contain levonorgestrel, making drospirenone a less than ideal first line contraceptive.
Meanwhile, a second study also published in the British Medical Journal (04/21/11) found that woman who used birth control that contained drospirenone had approximately double the risk of non-fatal venous thromboembolism as women who used a birth control that contained levonorgestrel.
According to the website, Beyaz is a birth control pill that also provides a daily dose of folate, which is a B vitamin. Beyaz is approved to prevent pregnancy, provide daily folate supplementation and treat premenstrual dysphoric disorder. Beyaz is manufactured by Bayer HealthCare Pharmaceuticals.
Beyaz Legal Help
If you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on May-10-13
BEYAZ ARTICLES AND INTERVIEWS
Beyaz Side Effects: More Birth Control Options Not Necessarily Better
For many women, the availability of Beyaz birth control
has meant more options in contraception. But for some women, Beyaz side effects have meant their lives have drastically changed, leading critics to ask if more birth control options really are better for women, given that older methods of contraception are just as effective and, as suggested by studies, less likely to have the same risk of side effects of Beyaz and other fourth-generation birth control pills [READ MORE]
Is a Beyaz Lawsuit a Simple Component of Doing Business for Bayer?
While Beyaz manufacturer Bayer A.G. continues to stand behind its drospirenone-based oral contraceptive as safe and effective, Beyaz side effects
are nonetheless articulated in both Beyaz advertising and corporate reporting [READ MORE]
Concerns About Beyaz Being Used to Control Menstruation
When women take Beyaz birth control
as a contraceptive, they do so hoping the benefits of preventing pregnancy outweigh the risk of Beyaz side effects. Of course, they can only do this if they have been made fully aware of the side effects of Beyaz. But sometimes, Beyaz is prescribed not to prevent pregnancy but to treat symptoms of menstruation, a use that some critics have serious concerns about [READ MORE]
YOUR BEYAZ STORIES
Publish your Beyaz experience here for our readers to learn from.